Hormesis: Toxicological foundations and role in aging research

Experimental Gerontology

Volumn 48, Issue 1, 2013, Pages 99-102

  Calabrese, Edward J ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Biphasic; Hormesis; Hormetic; Linear model; Risk assessment; Threshold model

Indexed keywords

ANTINEOPLASTIC AGENT;

AGING; ARTICLE; BIOMEDICINE; HORMESIS; HUMAN; LIFESPAN; LONGEVITY; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; STATISTICAL MODEL; TOXICOLOGY; VALIDITY;

AGING; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTORY, 20TH CENTURY; HOMEOPATHY; HORMESIS; HUMANS; MODELS, BIOLOGICAL; PHARMACOLOGY; TOXICOLOGY;

ANIMALIA;

EID: 84872036965     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.02.004     Document Type: Article

References (60)

1. Accomazzo M.T., Cattaneo S., Nicosia S., Rovati G.E. Bell-shaped curves for prostaglandin-induced modulation of adenylate cyclase: two mutually opposing effects. Eur. J. Pharmacol. 2002, 454:107-114.
2. Alfonzo M.J., de Becemberg I.L., de Villaroel S.S., de Herrera V.N., Misle A.J., de Alfonzo R.G. Two opposite signal transducing mechanisms regulate a G-protein-coupled guanylyl cyclase. Arch. Biochem. Biophys. 1998, 350:19-25.
3. Ames B.N., Gold L.S. Environmental pollution, pesticides, and the prevention of cancer: misconceptions. FASEB J. 1997, 11:1041-1052.
4. H. Bohme, 1986. Hugo Schulz (8/6/1853-7/13/1932). His life and work. Dissertation, Freien University of Berlin. Berlin, Germany.
5. Calabrese E.J. Chemical hormesis: its historical foundations as a biological hypothesis. Hum. Exper. Toxicol. 2000, 19:2-31.
6. Calabrese E.J. Radiation hormesis: its historical foundations as a biological hypothesis. Hum. Exper. Toxicol. 2000, 19:41-75.
7. Calabrese E.J. The effects of gamma rays on longevity. Biogerontology 2000, 1:309-319.
8. Calabrese E.J. Toxicology rewrites its history and rethinks its future: giving equal focus to both harmful and beneficial effects. Environ. Toxicol. Chem. 2011.
9. Calabrese E.J. Hormesis is central to toxicology, pharmacology and risk assessment. Hum. Exper. Toxicol. 2010, 29:249-261.
10. Calabrese E.J. Hormesis: why it is important to toxicology and toxicologists. Environ. Toxicol. Chem. 2008, 27:1451-1474.
11. Calabrese E.J. Historical blunders: how toxicology got the dose-response relationship half right. Cell. Mol. Biol. 2005, 51:643-654.
12. Calabrese E.J. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose-response model in the toxicological sciences. Environ. Pollut. 2005, 138:378-411.
13. Calabrese E.J., Baldwin L.A. The hormetic dose-response model is more common than the threshold model in toxicology. Toxicol. Sci. 2003, 71:246-250.
14. Calabrese E.J., Baldwin L.A. Hormesis: U-shaped dose responses and their centrality in toxicology. TiPS 2001, 22:285-291.
15. Calabrese E.J., Baldwin L.A. The frequency of U-shaped dose responses in the toxicological literature. Toxicol. Sci. 2001, 62:330-338.
16. Calabrese E.J., Jonas W.B. Homeopathy: clarifying its relationship to hormesis. Hum. Exper. Toxicol. 2010, 29(7):531-536.
17. Calabrese E.J., Jonas W.B. Evaluating homeopathic drugs within a biomedical framework. Hum. Exper. Toxicol. 2010, 29(7):545-549.
18. Calabrese E.J., Hoffmann G.R., Stanek E.J., Nascarella M.A. Hormesis in high-throughput screening of antibacterial compounds in E coli. Hum. Exper. Toxicol. 2010, 29:667-677.
19. Calabrese E.J., Stanek E.J., Nascarella M.A., Hoffmann G.R. Hormesis predicts low-dose responses better than threshold models. Int. J. Toxicol. 2008, 27:369-378.
20. Calabrese E.J., Staudenmayer J.W., Stanek E.J., Hoffmann G.R. Hormesis outperforms threshold model in NCI anti-tumor drug screening data. Toxicol. Sci. 2006, 94:368-378.
21. Calabrese V., Cornelius C., Stella A.M.G., Calabrese E.J. Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes. Neurochem. Res. 2010, 35(12):1880-1915.
22. Caratero A., Courtade M., Bonnet L., Planel H., Caratero C. Effect of a continuous gamma irradiation at a very low dose on the life span of mice. Gerontology 1998, 44:272-276.
23. 2) receptors in perfused rat hindlimb. Life Sci. 1995, 57:91-102.
24. Cork J.M. Gamma-radiation and longevity of the flour beetle. Rad. Res. 1957, 7:551-557.
25. Cypser J.R., Johnson T.E. Multiple stressors in Caenorhabditis elegans induce stress hormesis and extended longevity. J. Gerontol. Series A 2002, 57(3):B109-B114.
26. Halm D.R., Halm S.T. Prostanoids stimulate K secretion and Cl secretion in guinea pig distal colon via distinct pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281:G984-G996.
27. Hao M., Zhao Y., Chen P., Huang H., Liu H., Jiang H., Zhang R., Wang H. Structure-activity relationship and substrate-dependent phenomena in effects of ginsenosides on activities of drug-metabolizing P450 enzymes. PLoS One 2008, 3:e2697. 10.1371/journal.pone.0002697.
28. Hercus M.J., Loeschcke V., Rattan S.I.S. Lifespan extension of Drosophila melanogaster through hormesis by repeated mild heat stress. Biogerontology 2003, 4:149-156.
29. Ina Y., Sakai K. Prolongation of life span associated with immunological modification by chronic low-dose-rate irradiation in MRL-lpr/lpr mice. Rad. Res. 2004, 161:168-173.
30. Ina Y., Sakai K. Further study of prolongation of life span associated with immunological modification by chronic low-dose-rate irradiation in MRL-lpr/lpr mice: effects of whole-life irradiation. Rad. Res. 2005, 163:418-423.
31. Kahn A., Olsen A. Stress to the rescue: is hormesis a 'cure' for aging?. Dose-Response 2010, 8(1):48-52.
32. Kitani K., Kanai S., Miyasaka K., Carrillo M.-C., Ivy G.O. Dose-dependency of life span prolongation of F344/DuCrj rats injected with (-)deprenyl. Biogerontol. 2005, 6:297-302.
33. Kitani K., Minami C., Isobe K.-I., Maehara K., Kanai S., Ivy G.O., Carrillo M.-C. Why (-)deprenyl prolongs survivals of experimental animals: increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects. Mech. Age. Dev. 2002, 123:1087-1100.
34. Le Bourg E. Using Drosophila melanogaster to study the positive effects of mild stress on aging. Exper. Gerontol. 2011, 46:345-348.
35. Mild stress and healthy aging. Applying Hormesis in Aging Research and Interventions 2008, 187. Springer. E. Le Bourg, S.I.S. Rattan (Eds.).
36. Leff P. Theoretical treatment of one-agonist-2-receptor systems. TiPS 1994, 15:320-321.
37. Marques F.Z., Markus M.A., Morris B.J. Hormesis as a pro-health aging intervention in human beings?. Dose-Response 2010, 8(1):28-33.
38. Martius-Rostock F. The Arndt-Schulz axiom, The Munich Medical Weekly News 70(31):1-4. August 1923, 2:1923.
39. Masoro E.J. Hormesis and the antiaging action of dietary restriction. Exper Gerontology 1998, 33(1-2):61-66.
40. Massie H.R., Whitney S.J.P. Effect of shielding from environmental neutrons on the life span of Drosophila: preliminary evidence. Age 1993, 16:31-34.
41. Hormesis: A Revolution in Biology, Toxicology and Medicine 2010, 213. Humana Press, Inc. M.P. Mattson, E.J. Calabrese (Eds.).
42. i3 activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling. Mol. Pharmacol. 2002, 62:590-601.
43. Olsen A., Vantipalli M.C., Lithgow G.J. Lifespan extension of Caenorhabditis elegans following repeated mild hormetic heat treatments. Biogerontology 2006, 7(4):221-230.
44. Pardon M.C. Hormesis is applicable as a pro-healthy aging intervention in mammals and human beings. Dose-Response 2010, 8(1):22-27.
45. Pliska V. Models to explain dose-response relationships that exhibit a downturn phase. TiPS 1994, 15:178-181.
46. 2 in human non-pregnant myometrium. Eur. J. Pharmacol. 2001, 416:145-152.
47. Rattan S.I.S. Hormetic mechanisms of anti-aging and rejuvenating effects of repeated mild heat stress on human fibroblasts in vitro. Rejuv. Res. 2004, 7(1):40-48.
48. Ristow M., Schmeisser S. Extending life span by increasing oxidative stress. Free Rad. Biol. Med. 2011, 51(2):327-336.
49. Rovati G.E., Nicosia S. An alternative model for bell-shaped concentration-response curves - reply. TiPS 1994, 15:321-322.
50. Sak K., Barnard E.A., Jarv J. Dual effect of nucleotides on P2Y receptors. IUBMB Life 2000, 50:99-103.
51. Salminen A., Kaarniranta K. ER stress and hormetic regulation of the aging process. Age. Res. Rev. 2010, 9(3):211-217.
52. Sarup P., Loeschcke V. Life extension and the position of the hormetic zone depends on sex and genetic background in Drosophila melanogaster. Biogerontology 2011, 12:109-117.
53. Schulz H. Zur Lehre von der Arzneiwirkung. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 1887, 108(3):423-445.
54. Schulz H. Ueber Hefegifte. Pfluegers Arch. Gesame Physiol. Menschen Tiere 1888, 42(1):517-541.
55. Szabadi E. Model of 2 functionally antagonistic receptor populations activated by same agonist. J. Theoret. Biol. 1977, 69:101-112.
56. Vaiserman A.M., Koshel N.M., Litoshenko A.Y., Mozzhukhina T.G., Voitenko V.P. Effects of x-irradiation in early ontogenesis on the longevity and amount of the S1 nuclease-sensitive DNA sites in adult Drosophila melanogaster. Biogerontol. 2003, 4:9-14.
57. Venter D.P. Indirectly acting agonists - a model for the functional interaction of released endogenous double agonists. Eur. J. Pharmacol. 1994, 251:2-3.
58. Verbeke P., Deries M., Clark B.F.C., Rattan S.I.S. Hormetic action of mild heat stress decreases the inducibility of protein oxidation and glycoxidation in human fibroblasts. Biogerontology 2002, 3:117-120.
59. Wels P. The life time work of Hugo Schulz. Naunyn-Schmiedebergs Archiv. Exp. Pathol. Pharmakol. 1933, 170:744-757.
60. Zhu B.T. Rational design of receptor partial agonists and possible mechanisms of receptor partial activation: a theory. J. Theor. Biol. 1996, 181:273-291.